NCT03773055View on ClinicalTrials.gov

Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Neuropathic Pain in Cancer
Interventions
DRUG

NPC-06

Patients will receive once a day for 7 days.

Trial Locations (1)

160-8582

Keio Hospital, Shinjuku-Ku

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT03773055 - Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer | Biotech Hunter | Biotech Hunter